Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD derivatives

June 22, 2021 CD derivatives / Supramolecular systems

The macroscopic shape of assemblies formed from microparticles based on host–guest interaction

Biological macroscopic assemblies have inspired researchers to utilize molecular recognition to develop smart materials in these decades. Recently, macroscopic self-assemblies

Continue reading

June 17, 2021 CD derivatives / Drug delivery / Pharma applications / Supramolecular systems

Nonviral DNA Delivery System with Supramolecular PEGylation Formed by Host–Guest Pseudo-Block Copolymers

A cationic supramolecular system based on host–guest pseudoblock copolymers was developed for nonviral DNA delivery. In this system, the macromolecular

Continue reading

June 16, 2021 CD derivatives / Drug delivery / Pharma applications

European Patent Office upholds Curadev’s SBE-β-CD patent for new composition of matter

Yahoo Finance published: Working with Professor Steve Wicks and his team at the University of Greenwich, Curadev developed a new method for

Continue reading

June 15, 2021 CD as API / CD derivatives / Pharma applications

Antibacterial and Cytotoxic Effects of Cyclodextrin-Triazole-Titanium Based Nanocomposite

The antibacterial activity of triazole functionalized cyclodextrin (CD.Click) and cyclodextrin-triazole-titanium based nanocomposite (CD.COM) was evaluated. The results indicated that CD.Click

Continue reading

June 14, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Molecular lipophilic potential of cyclodextrins

A recent review of Jicsinszky et al. (2021) gave an overview on cyclodextrins’ benefits and limitations in various antiviral drug

Continue reading

June 11, 2021 CD as API / CD derivatives / Pharma applications

Weakly acidic carboxy group-grafted β-cyclodextrin-threaded acid-degradable polyrotaxanes for modulating protein interaction and cellular internalization

To improve the therapeutic potential of β-cyclodextrin (β-CD)-threaded acid-degradable polyrotaxanes (β-CD PRXs) in cholesterol-related metabolic disorders, the effect of carboxylation

Continue reading

June 3, 2021 CD as API / CD derivatives / Pharma applications

Nitric oxide and COVID-19

A clinical trial in United Kingdom confirms SaNOtize’s breakthrough treatment for COVID-19 SaNOtize R. & D. Corp, a Canadian Biotech

Continue reading

May 31, 2021 CD derivatives / Drug delivery / Pharma applications

Pharmaceutical formulation of lonafarnib with sulfobutylether beta cyclodextrin

A PCT patent application on lonafarnib / SBECD formulation was published on 20 May 2021 (WO2021095008, CycloLab, Hungary). By using

Continue reading

May 25, 2021 CD derivatives

Hepta-differentiated beta-cyclodextrin was obtained through a programmed synthesis

Precise heterofunctionalisation of cyclodextrins is a well-known bottleneck in the chemistry of cyclodextrins. In fact, although many applications of cyclodextrins

Continue reading

May 19, 2021 CD as API / CD derivatives / Pharma applications

Sensitive quantification of carbon monoxide in vivo reveals a protective role of circulating hemoglobin in CO intoxication.

Carbon monoxide (CO) is a gaseous molecule known as the silent killer. It is widely believed that an increase in

Continue reading

Posts pagination

«Previous Posts 1 … 22 23 24 25 26 … 40 Next Posts»

Recent Posts

  • HPβCD’s Promise in Treating Ischemic Stroke
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (340)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,157)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • HPβCD's Promise in Treating Ischemic Stroke
  • Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
  • Lanosterol eye drops for cataract treatment
  • Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application
  • Sun-protective clothing using benzophenone/CD complex
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
  • Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...